Conformal proton therapy for early-stage prostate cancer

Urology

Volumn 53, Issue 5, 1999, Pages 978-983

  Slater, Jerry D ^a   Rossi Jr , Carl J ^a   Yonemoto, Leslie T ^a   Reyes Molyneux, Nancy J ^a   Bush, David A ^a   Antoine, John E ^a   Miller, Daniel W ^a   Teichman, Sandra L ^a   Slater, James M ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; PROTON RADIATION; RADIATION DOSE;

EID: 0032969619     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00014-X     Document Type: Article

References (40)

1. Parker S.L., Tong T., Bolden S., et al. Cancer statistics, 1997. CA Cancer J Clin. 47:1997;5-27.
2. Baker L.H., Hanks G., Gershenson D., et al. NCCN Prostate Cancer Practice Guidelines. Oncology (Huntingt). 10:1996;265-288.
3. Zagars G.K., Pollack A. Radiation therapy for T1 and T2 prostate cancer prostate-specific antigen and disease outcome . Urology. 45:1995;476-483.
4. Kuban D.A., el-Mahdi A.M., Schellhammer P.F. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 32:1995;307-316.
5. Zietman A.L., Coen J.J., Dallow K.C., et al. The treatment of prostate cancer by conventional radiation therapy an analysis of long-term outcome . Int J Radiat Oncol Biol Phys. 32:1995;287-292.
6. Zietman A.L., Coen J.J., Shipley W.U., et al. Radical radiation therapy in the management of prostatic adenocarcinoma the initial prostate specific antigen value as a predictor of treatment outcome . J Urol. 151:1994;640-645.
7. Corn B.W., Hanks G.E., Schultheiss T.E., et al. Conformal treatment of prostate cancer with improved targeting superior prostate-specific antigen response compared to standard treatment . Int J Radiat Oncol Biol Phys. 32:1995;325-330.
8. Hanks G.E., Hanlon A., Schultheiss T., et al. Early prostate cancer the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation . J Urol. 152:1994;1775-1780.
9. Hanks G.E., Lee W.R., Schultheiss T.E. Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation. J Urol. 154:1995;456-459.
10. Hanks G.E., Martz K.L., Diamond J.J. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys. 15:1988;1299-1305.
11. Leibel S.A., Zelefsky M.J., Kutcher G.J., et al. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate interim report of a phase 1 dose-escalation study . J Urol. 152:1994;1792-1798.
12. Leibel S.A., Heimann R., Kutcher G.J., et al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate preliminary results of a phase I dose-escalation study . Int J Radiat Oncol Biol Phys. 28:1994;55-65.
13. Sandler H.M., McShan D.L., Lichter A.S. Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution. Int J Radiat Oncol Biol Phys. 22:1992;361-367.
14. Sandler H.M., McLaughlin P.W., Ten Haken R.K., et al. Three dimensional conformal radiotherapy for the treatment of prostate cancer low risk of chronic rectal morbidity observed in a large series of patients . Int J Radiat Oncol Biol Phys. 33:1995;797-801.
15. Shipley W.U., Tepper J.E., Prout G.R. Jr, et al. Proton radiation as boost therapy for localized prostatic carcinoma. JAMA. 241:1979;1912-1915.
16. Yonemoto L.T., Slater J.D., Rossi C.J. Jr, et al. Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate preliminary results of a phase I/II study . Int J Radiat Oncol Biol Phys. 37:1997;21-29.
17. Archambeau J.O., Bennett G.W., Levine G.S., et al. Proton radiation therapy. Radiology. 110:1974;445-457.
18. Austin-Seymour M., Munzenrider J., Linggood R., et al. Fractionated proton radiation therapy of cranial and intracranial tumors. Am J Clin Oncol. 13:1990;327-330.
19. Slater J.M., Archambeau J.O., Miller D.W., et al. The proton treatment center at Loma Linda University Medical Center rationale for and description of its development . Int J Radiat Oncol Biol Phys. 22:1992;383-389.
20. Goitein M., Abrams M. Multi-dimensional treatment planning I.Delineation of anatomy . Int J Radiat Oncol Biol Phys. 9:1983;777-787.
21. Goitein M., Abrams M., Rowell D., et al. Multi-dimensional treatment planning II.Beam's eye-view, back projection, and projection through CT sections . Int J Radiat Oncol Biol Phys. 9:1983;789-797.
22. Zietman A.L., Tibbs M.K., Dallow K.C., et al. Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate. Radiother Oncol. 40:1996;159-162.
23. Cox J., Grignon D., Kaplan R., et al. Consensus statement guidelines for PSA following radiation therapy . Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
24. Pilepich M.V., Asbell S.O., Krall J.M., et al. Correlation of radiotherapeutic parameters and treatment related morbidity - analysis of RTOG Study 77-06. Int J Radiat Oncol Biol Phys. 13:1987;1007-1012.
25. Lawton C.A., Won M., Pilepich M.V., et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate analysis of RTOG studies 7506 and 7706 . Int J Radiat Oncol Biol Phys. 21:1991;935-939.
26. Schultheiss T.E., Lee W.R., Hunt M.A., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;3-11.
27. Hanks G.E., Schultheiss T.E., Hanlon A.L., et al. Optimization of conformal radiation treatment of prostate cancer report of a dose escalation study . Int J Radiat Oncol Biol Phys. 37:1997;543-550.
28. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
29. Cox D: Regression models and life tables (with discussion). J R Stat Soc B34: 187-220, 1972.
30. Crook J., Bahadur Y., Bociek R. Radiotherapy for localized prostate carcinoma. Cancer. 79:1996;328-336.
31. Critz F.A., Levinson A.K., Williams W.H., et al. Prostate-specific antigen nadir the optimum level after irradiation for prostate cancer . J Clin Oncol. 14:1996;2893-2900.
32. Zagars G.K., Pollack A., Kavadi V.S., et al. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 32:1995;293-306.
33. Lee W.R., Hanks G.E., Schultheiss T.E., et al. Localized prostate cancer treated by external-beam radiotherapy alone serum prostate-specific antigen - driven outcome analysis . J Clin Oncol. 13:1995;464-469.
34. Zagars G.K., Pollack A., von Eschenbach A.C. Prognostic factors for clinically localized prostate carcinoma analysis of 938 patients irradiated in the prostate specific antigen era . Cancer. 79:1997;1370-1380.
35. Shipley W.U., Verhey L.J., Munzenrider J.E., et al. Advanced prostate cancer the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone . Int J Radiat Oncol Biol Phys. 32:1995;3-12.
36. Rossi C.J. Jr, Slater J.D., Reyes-Molyneux N., et al. Particle beam radiation therapy in prostate cancer is there an advantage? Semin Radiat Oncol. 8:1998;115-123.
37. Paulson D.F., Moul J.W., Walther P.J. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma long-term results . J Urol. 144:1990;1180-1184.
38. Zincke H., Bergstralh E.J., Blute M.L., et al. Radical prostatectomy for clinically localized prostate cancer long-term results of 1,143 patients from a single institution . J Clin Oncol. 12:1994;2254-2263.
39. Gerber G.S., Thisted R.A., Scardino P.T., et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA. 276:1996;615-619.
40. Partin A.W., Pound C.R., Clemens J.Q., et al. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am. 20:1993;713-725.